Gongwin Biopharm Holdings Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 5.44 million. Net loss was TWD 25.46 million compared to TWD 21.73 million a year ago.

Basic loss per share from continuing operations was TWD 0.22 compared to TWD 0.19 a year ago.